{
  "ticker": "CU6",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02975981",
  "id": "02975981",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250801",
  "time": "1502",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250801/pdf/06mfntsxgsdt5b.pdf",
  "summary": "- **Substantial Holder Ceasing**: TM Ventures Pty Ltd ceased to be a substantial holder in Clarity Pharmaceuticals Ltd on **01/08/2025**.  \n- **Recent Sales**:  \n  - Sold **400,000** ordinary shares on **06/05/2024** for **$1.51M** (on-market).  \n  - Sold **600,000** ordinary shares on **07/05/2024** for **$2.22M** (on-market).  \n  - Sold **600,000** ordinary shares on **08/05/2024** for **$2.21M** (on-market).  \n  - Sold **267,312** ordinary shares on **17/06/2024** for **$1.39M** (on-market).  \n  - Subsequent smaller sales in June 2024.  \n- **Dilution Event**: TM Ventures' stake was further diluted due to a capital raise by Clarity Pharmaceuticals on **01/08/2025** (no details provided on the raise).  \n\n**Key Implications**: Significant sell-down by TM Ventures (~2.0M shares in May\u2013June 2024) suggests reduced insider confidence or portfolio rebalancing. Dilution indicates potential equity issuance by Clarity (details undisclosed). Monitor for further capital raising announcements.",
  "usage": {
    "prompt_tokens": 1442,
    "completion_tokens": 277,
    "total_tokens": 1719,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-08-01T05:57:58.590735"
}